ISU ABXIS
Isu Abxis provides value-added treatment methods based on biotechnology to improve the quality of life of refractory patients suffering from cancer and rare diseases , provide members with opportunities for self-realization, They are constantly striving to become a company that can contribute to society through management .
ISU ABXIS
Industry:
Biotechnology Health Care
Founded:
2001-03-28
Address:
Seongnam, Kyonggi-do, South Korea
Country:
South Korea
Website Url:
http://www.abxis.com
Total Employee:
101+
Status:
Active
Contact:
031) 696-4700
Email Addresses:
[email protected]
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible Google Universal Analytics Global Site Tag Java EE GlobalSign AlphaSSL SK Broadband
Official Site Inspections
http://www.abxis.com Semrush global rank: 4.66 M Semrush visits lastest month: 2.1 K
- Host name: 175.119.100.131
- IP address: 175.119.100.131
- Location: Songpa-dong South Korea
- Latitude: 37.5082
- Longitude: 127.1179
- Timezone: Asia/Seoul
- Postal: 05670
More informations about "Isu Abxis"
ISU ABXIS
ISU ABXIS has signed a license agreement for “Fabagal” a therapeutic for Fabry disease, with NPO 2021-10-05. ISU ABXIS to Present at Neuroscience 2021. ISU ABXIS to Present at …See details»
Abaxis Global Diagnostics | Better at Point of Care | Abaxis
The gold standard in point‐of‐care blood chemistry, The Piccolo Xpress delivers real-time, diagnostic-grade results at the point of care for immediate treatment planning and patient …See details»
Abaxis - Wikipedia
Abaxis was founded by Gary H. Stroy, Richard Leute, and Vladimir E. Ostoich in April 1989. It was founded to develop a machine capable of analyzing blood and provide doctors readings on 80 tests within a few minutes. The company was originally based in Mountain View, California until 1992, when it moved its headquarters to Sunnyvale, California. Also in 1992, the company completed its initial public offeringSee details»
ISU ABXIS
Founded in 2001 with the goal of developing innovative antibody-based therapeutics to treat cancer, the name ABXIS is a reflection of our dedication to become an axis of antibody (Ab) …See details»
ISU GROUP - ABXIS
The ISU Group established a holding company ISU Co., Ltd., in August 1, 2003, to meet social needs and interests for the improvement in corporate governance and transparent management.See details»
ISU Abxis Company Description - Stock Analysis
Nov 21, 2024 ISU Abxis Co., Ltd., a biopharmaceutical company, develops and markets products for the treatment of cancer and rare diseases worldwide. The company offers …See details»
Company ISU Abxis Co., Ltd. - MarketScreener.com
Dec 9, 2024 ISU Abxis Co., Ltd. is a Korea-based company mainly engaged in the biopharmaceutical business. The Company operates its business under two divisions: …See details»
Isu Abxis - Crunchbase Company Profile & Funding
Contact Email [email protected] Phone Number 031) 696-4700 Isu Abxis provides value-added treatment methods based on biotechnology to improve the quality of life of refractory patients …See details»
Abaxis - Crunchbase Company Profile & Funding
At Abaxis our mission is to supply point of care blood analyzers to the medical market and the veterinarian market. Abaxis provides leading edge technology, tools and services that support …See details»
Isu Abxis Company Profile | Management and Employees List
Isu Abxis Profile and History. We have been dedicated to actualizing our philosophy and the activities include production of raw materials for environmentally-friendly detergent, cutting …See details»
Pioneering Engineered Antibody Immunotherapy - ABXIS
2000’s 2001 03 Foundation of ISU ABXIS 2006 12 MFDS approval for Clotinab®(the first antibody approved in Korea) 2009 02 IPO on KOSDAQ via special tracks based on technology …See details»
ISU Abxis Co., Ltd. - Drug pipelines, Patents, Clinical trials - Synapse
Explore ISU Abxis Co., Ltd. with its drug pipeline, therapeutic area, technology platform, 12 clinical trials, and 13 literature, Disease Domain:Nervous System ...See details»
ISU ABXIS Company Profile - Office Locations, Competitors ... - Craft
ISU ABXIS ₩54.31 b in annual revenue in FY 2023. See insights on ISU ABXIS including office locations, competitors, revenue, financials, executives, subsidiaries and more at Craft.See details»
Better at Point of Care - Abaxis
Zoetis Inc. completed the acquisition of Abaxis Inc. on July 31, 2018. Abaxis shareholders can find more information about the transaction and the merger considerationSee details»
ISU Abxis - Products, Competitors, Financials, Employees, …
ISU Abxis. Frequently Asked Questions (FAQ) When was ISU Abxis founded? ISU Abxis was founded in 2001. Where is ISU Abxis's headquarters? ISU Abxis's headquarters is located at …See details»
History - ISU ABXIS
2021. 09. Presentation of final data from Phase 1 study of ISU104 at ESMO. 07. The grant of a patent for Barecetamab(ISU104) by the EPO(European Patent Office)See details»
What is ISU ABXIS? Company Culture, Mission, Values
ISU ABXIS. Is this your company? This employer has not claimed their Employer Profile and is missing out on connecting with our community. Connect with our community. Claim your Free …See details»
Better at Point of Care - Abaxis
Hospitals and IDNs are realizing the benefits of POCT. Point-of-care diagnostics are commonplace within today’s Integrated Delivery Networks. Hospital administrators, care …See details»
ISU ABXIS
If you have experienced any type of adverse event or adverse drug reaction related to ISU ABXIS products, please report it to us at the contact information below: Call: +82-31-696-4631 …See details»
ISU Abxis Co., Ltd. (ISU Abxis Co., Ltd.) - 药物管线_专利_临床试验_ …
了解ISU Abxis Co., Ltd. (ISU Abxis Co., Ltd.)公司的药物管线，治疗领域，技术平台，以及它的12项临床试验, 3篇新闻和9篇文献，疾病领域:神经系统疾病，内分泌与代谢疾病，肿瘤，免疫 …See details»